Eur Rev Med Pharmacol Sci 2020; 24 (24): 12694-12700
DOI: 10.26355/eurrev_202012_24167

MiRNA-15a-3p inhibits the metastasis of hepatocellular carcinoma by interacting with HMOX1

C. Jiang, Z.-L. He, X.-H. Hu, P.-Y. Ma

Department of Hepatobiliary Surgery, Hunan Provincial People’s Hospital, Changsha, China. 1512440220@st.usst.edu.cn


OBJECTIVE: To uncover the relationship between microRNA-15a-3p (miRNA-15a-3p) level and clinical features of hepatocellular carcinoma (HCC), and to explore the influence of miRNA-15a-3p on metastasis of HCC cells.

PATIENTS AND METHODS: HCC and paracancerous tissues were surgically resected from 44 HCC patients. Their clinical data and follow-up files were recorded. Differential expressions of miRNA-15a-3p in HCC samples were determined. The relationship between miRNA-15a-3p level and clinical features of HCC patients was analyzed. Changes in proliferative, migratory and invasive potentials in Huh7 and HepG2 cells overexpressing miRNA-15a-3p were examined. The downstream gene of miRNA-15a-3p and its involvement in HCC development were finally explored.

RESULTS: MiRNA-15a-3p was downregulated in HCC tissues. High metastasis rate and poor prognosis were observed in HCC patients expressing a low level of miRNA-15a-3p. Overexpression of miRNA-15a-3p attenuated proliferative, migratory and invasive potentials in HCC. Protein levels of HMOX1, CD31, c-Myc, MMP-2 and MMP-9 were downregulated in HCC cells after overexpression of miRNA-15a-3p. HMOX1 was the downstream gene of miRNA-15a-3p, which was upregulated in HCC samples. Highly expressed HMOX1 was unfavorable to the prognosis in HCC. Overexpression of HMOX1 abolished the regulatory effects of miRNA-15a-3p on HCC cell phenotypes.

CONCLUSIONS: MiRNA-15a-3p is closely linked to lymphatic metastasis, distant metastasis and poor prognosis in HCC. It inhibits the malignant development of HCC by interacting with HMOX1

Free PDF Download

To cite this article

C. Jiang, Z.-L. He, X.-H. Hu, P.-Y. Ma
MiRNA-15a-3p inhibits the metastasis of hepatocellular carcinoma by interacting with HMOX1

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 24
Pages: 12694-12700
DOI: 10.26355/eurrev_202012_24167